BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31486298)

  • 21. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer.
    Jiang X; Wang W; Yang Y; Du L; Yang X; Wang L; Zheng G; Duan W; Wang R; Zhang X; Wang L; Chen X; Wang C
    Oncotarget; 2017 Sep; 8(39):65132-65142. PubMed ID: 29029418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A radiomics-based model for prediction of lymph node metastasis in gastric cancer.
    Gao X; Ma T; Cui J; Zhang Y; Wang L; Li H; Ye Z
    Eur J Radiol; 2020 Aug; 129():109069. PubMed ID: 32464581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
    Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
    Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
    Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
    Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
    Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
    Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
    Cen SY; Fu KY; Shi Y; Jiang HL; Shou JW; You LK; Han WD; Pan HM; Liu Z
    Math Biosci Eng; 2020 Feb; 17(3):2557-2568. PubMed ID: 32233554
    [No Abstract]   [Full Text] [Related]  

  • 30. Prediction of the indication criteria for endoscopic resection of early gastric cancer.
    Park JH; Lee SH; Park JM; Park CS; Park KS; Kim ES; Cho KB
    World J Gastroenterol; 2015 Oct; 21(39):11160-7. PubMed ID: 26494970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer.
    Pyo JH; Lee H; Min BH; Lee JH; Choi MG; Lee JH; Sohn TS; Bae JM; Kim KM; Ahn HS; Jung SH; Kim S; Kim JJ
    PLoS One; 2016; 11(5):e0156207. PubMed ID: 27228258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer.
    Pyo JH; Shin CM; Lee H; Min BH; Lee JH; Kim SM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim KM; Kim HS; Jung SH; Kim JJ; Kim S;
    Ann Surg; 2016 Dec; 264(6):1038-1043. PubMed ID: 27828821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of lymph node metastasis in early gastric carcinomas diagnosed by WHO criteria in 379 Chinese patients.
    Fang C; Shi J; Sun Q; Gold JS; Xu GF; Liu WJ; Zou XP; Huang Q
    J Dig Dis; 2016 Aug; 17(8):526-537. PubMed ID: 27434552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer.
    Fu K; Li Y; Song J; Cai W; Wu W; Ye X; Xu J
    Front Genet; 2021; 12():650102. PubMed ID: 33936173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection.
    Goto A; Nishikawa J; Hideura E; Ogawa R; Nagao M; Sasaki S; Kawasato R; Hashimoto S; Okamoto T; Ogihara H; Hamamoto Y; Sakaida I
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1346-1350. PubMed ID: 29084076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
    Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
    World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.
    Wang YW; Zhu ML; Wang RF; Xue WJ; Zhu XR; Wang LF; Zheng LZ
    Tumour Biol; 2016 Jul; 37(7):8567-78. PubMed ID: 26733174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.
    Zhang L; Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zhao XM
    Oncotarget; 2016 Jan; 7(3):3587-98. PubMed ID: 26657296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.